EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres

Carolina Palamin Buonafine iD, Alexander E Dos Santos iD, Larissa Molina Favarello iD, Regielly C R Cognialli iD, Valerio R Aquino iD, Ana V A Mendes iD, Thais Guimarães iD, Teresa C T Sukiennik iD, Fabianne Carlesse iD, Paulo de Tarso O E Castro iD, Vania A Vicente iD, Elaine C Francisco iD und 1 weitere

Mycoses · 2026-03 · 69 (3)

DOI: 10.1111/myc.70149 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Mycoses, online erschienen am 03.03.2026. Verfasst von Carolina Palamin Buonafine und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório Especial de Micologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Antifungal Agents, Candida, Saccharomycetales, Fungemia. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a lack of contemporary studies addressing the prevalence rates and antifungal susceptibility of bloodstream infections (BSI) caused by rare yeasts (RY) from the Saccharomycotina subphylum.

Objectives

This 16‐year multicentre study (2007–2023) aimed to assess the prevalence and antifungal susceptibility of rare yeasts isolated from BSIs in 28 Brazilian tertiary care hospitals.

Methods

Yeasts from the Saccharomycotina subphylum, excluding common Candida species and Basidiomycota, were selected from BSI episodes. Species were identified using proteomics and molecular methods. Antifungal susceptibility testing was performed by EUCAST broth microdilution.

Results

Among 2655 BSI episodes, 100 (3.76%) involved rare yeasts. Prevalence showed a slight, non‐significant increase from 3.16% (2007–2015) to 4.17% (2016–2023; p = 0.183). A total of 11 genera and 20 species were identified, with Clavispora lusitaniae (20%), Wickerhamomyces anomalus (16%), Candida haemulonii (14%) and Candida duobushaemulonii (12%) being the most frequent species. Eight species, including Pichia kluyveri and Kodamaea ohmeri , appeared only in the latter period. Most rare yeasts showed low MICs to amphotericin B and anidulafungin, except for Clavispora lusitaniae , Candida haemulonii and Candida duobushaemulonii , which were less susceptible to amphotericin B. Wickerhamomyces anomalus and Candida duobushaemulonii also showed reduced susceptibility to fluconazole.

Conclusions

This study provides valuable insights into the prevalence rates, species distribution and antifungal susceptibility of rare yeasts causing BSIs in tertiary care hospitals. Our findings highlight the need for continuous surveillance, incorporation of new diagnostic and tailored therapeutic strategies to mitigate morbidity and mortality due to invasive infections caused by emerging fungal pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaSaccharomycetalesFungemiaAscomycotaHumansPrevalenceMicrobial Sensitivity TestsBrazilDrug Resistance, FungalTertiary Care Centers

Stichwörter der Autor:innen

CandidaCandidemiaFungemiaSaccharomycotina yeastsantifungal resistanceemerging yeast pathogensinvasive fungal infectionsrare yeast infections

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Laboratório Especial de Micologia, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
  • Antimicrobial Resistance Institute of São Paulo (ARIES), São Paulo, São Paulo, Brazil.
  • Universidade Federal Do Paraná, Curitiba, Paraná, Brazil.
  • Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
  • Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil.
  • Hospital São Rafael, Salvador, Brazil.

ORCID-Profile: Carolina Palamin Buonafine, Alexander E Dos Santos, Larissa Molina Favarello, Regielly C R Cognialli, Valerio R Aquino, Ana V A Mendes, Thais Guimarães, Teresa C T Sukiennik, Fabianne Carlesse, Paulo de Tarso O E Castro, Vania A Vicente, Elaine C Francisco, Arnaldo L Colombo

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Buonafine, C. P., Dos Santos, A. E., Favarello, L. M., Cognialli, R. C. R., Aquino, V. R., Mendes, A. V. A., Guimarães, T., Sukiennik, T. C. T., Carlesse, F., Castro, P. T. O. E., Vicente, V. A., Francisco, E. C., & Colombo, A. L. (2026). Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres. Mycoses, 69(3). https://doi.org/10.1111/myc.70149

Vancouver

Buonafine CP, Dos Santos AE, Favarello LM, Cognialli RCR, Aquino VR, Mendes AVA, et al. Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres. Mycoses. 2026;69(3). doi:10.1111/myc.70149

BibTeX
@article{Buonafine2026,
  author = {Buonafine, Carolina Palamin and Dos Santos, Alexander E and Favarello, Larissa Molina and Cognialli, Regielly C R and Aquino, Valerio R and Mendes, Ana V A and Guimarães, Thais and Sukiennik, Teresa C T and Carlesse, Fabianne and Castro, Paulo de Tarso O E and Vicente, Vania A and Francisco, Elaine C and Colombo, Arnaldo L},
  title = {Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related Saccharomycotina Yeasts Causing Bloodstream Infections in 28 Medical Centres},
  journal = {Mycoses},
  year = {2026},
  volume = {69},
  number = {3},
  doi = {10.1111/myc.70149}
}
Kostenlos starten →